Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 3:14 pm Purchase |
2022-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
LYTTON LAURENCE W | 16,081 4.990% |
2,155 (+15.47%) |
Filing History |
| 2022-11-02 8:03 pm Purchase |
2022-10-25 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors Inc. | 71,942 9.970% |
51,768 (+256.60%) |
Filing History |
| 2022-10-25 06:01 am Purchase |
2022-10-21 | 13G | Cellectar Biosciences, Inc. CLRB |
Lincoln Park Capital Fund LLC | 31,253 9.990% |
23,541 (+305.24%) |
Filing History |
| 2022-02-14 7:44 pm Sale |
2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
LYTTON LAURENCE W | 13,926 6.600% |
-1,887 (-11.94%) |
Filing History |
| 2022-02-14 1:58 pm Sale |
2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Consonance Capital Management LP | 0 0.000% |
-15,678 (Position Closed) |
Filing History |
| 2022-02-10 4:02 pm Sale |
2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Sio Capital Management LLC | 0 0.000% |
-7,770 (Position Closed) |
Filing History |
| 2022-01-21 3:49 pm Purchase |
2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors Inc. | 20,174 9.970% |
9,484 (+88.71%) |
Filing History |
| 2021-07-08 1:30 pm Purchase |
2021-06-30 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors Inc. | 10,691 6.000% |
10,691 (New Position) |
Filing History |
| 2021-02-17 3:10 pm Sale |
2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Consonance Capital Management LP | 15,678 9.990% |
-4,517 (-22.37%) |
Filing History |
| 2021-02-16 5:10 pm Purchase |
2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Boxer Capital LLC | 6,133 4.000% |
3,027 (+97.47%) |
Filing History |
| 2021-02-16 2:20 pm Purchase |
2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Consonance Capital Management LP | 20,195 9.990% |
20,195 (New Position) |
Filing History |
| 2021-02-16 1:03 pm Purchase |
2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Sio Capital Management LLC | 7,770 8.690% |
7,770 (New Position) |
Filing History |
| 2021-02-16 11:26 am Purchase |
2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
LYTTON LAURENCE W | 15,813 9.990% |
7,805 (+97.45%) |
Filing History |
| 2021-02-16 07:22 am Purchase |
2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
North Sound Trading, LP | 7,217 4.800% |
4,133 (+134.05%) |
Filing History |